n-(1-methyl-2-phenylethyl)adenosine and Chronic Disease

n-(1-methyl-2-phenylethyl)adenosine has been researched along with Chronic Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hao, JX; Sollevi, A; von Heijne, M; Wiesenfeld-Hallin, Z; Xu, XJ; Yu, W	1

Other Studies

1 other study(ies) available for n-(1-methyl-2-phenylethyl)adenosine and Chronic Disease

Article	Year
Reduced anti-allodynic effect of the adenosine A1-receptor agonist R-phenylisopropyladenosine on repeated intrathecal administration and lack of cross-tolerance with morphine in a rat model of central pain. Anesthesia and analgesia, 1998, Volume: 87, Issue:6 Topics: Adenosine; Analgesics; Analgesics, Opioid; Animals; Chronic Disease; Drug Tolerance; Female; Injections, Spinal; Morphine; Pain; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries	1998

Article

Year

Reduced anti-allodynic effect of the adenosine A1-receptor agonist R-phenylisopropyladenosine on repeated intrathecal administration and lack of cross-tolerance with morphine in a rat model of central pain.

Anesthesia and analgesia, 1998, Volume: 87, Issue:6

Topics: Adenosine; Analgesics; Analgesics, Opioid; Animals; Chronic Disease; Drug Tolerance; Female; Injections, Spinal; Morphine; Pain; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries

1998